Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2001 1
2002 3
2003 1
2004 3
2005 4
2006 3
2007 4
2008 5
2009 3
2010 9
2011 4
2012 2
2013 5
2014 5
2015 7
2016 11
2017 11
2018 7
2019 12
2020 8
2021 8
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Winter D, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Sweeney CJ, et al. Lancet Oncol. 2023 Apr;24(4):323-334. doi: 10.1016/S1470-2045(23)00063-3. Lancet Oncol. 2023. PMID: 36990608 Clinical Trial.
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.
Kamrava M, Leung E, Bachand F, Beriwal S, Chargari C, D'Souza D, Erickson B, Fokdal L, Han K, Harkenrider M, Lin L, Mahantshetty U, Nesvacil N, Ravi A, Schmid M, Vigneault E, Westerveld H, Yashar C, Nout R. Kamrava M, et al. Among authors: vigneault e. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):654-663. doi: 10.1016/j.ijrobp.2022.09.072. Epub 2022 Oct 1. Int J Radiat Oncol Biol Phys. 2023. PMID: 36191741
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H. Michalski JM, et al. Among authors: vigneault e. JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039. Epub 2018 Jun 14. JAMA Oncol. 2018. PMID: 29543933 Free PMC article. Clinical Trial.
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Spratt DE, et al. Among authors: vigneault e. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):370-377. doi: 10.1016/j.ijrobp.2023.04.010. Epub 2023 May 2. Int J Radiat Oncol Biol Phys. 2023. PMID: 37137444 Clinical Trial.
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Among authors: vigneault e. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334
Treatment options for localized prostate cancer.
Keyes M, Crook J, Morton G, Vigneault E, Usmani N, Morris WJ. Keyes M, et al. Among authors: vigneault e. Can Fam Physician. 2013 Dec;59(12):1269-74. Can Fam Physician. 2013. PMID: 24336537 Free PMC article. Review.
In Regard to Bossi et al.
Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT. Fakhry C, et al. Among authors: vigneault e. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. Int J Radiat Oncol Biol Phys. 2018. PMID: 30238902 No abstract available.
The Practice of Radiation Oncology in Canada.
Lalani N, Cummings B, Halperin R, Rakovitch E, Brundage M, Vigneault E, Milosevic M. Lalani N, et al. Among authors: vigneault e. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):876-880. doi: 10.1016/j.ijrobp.2016.11.055. Epub 2016 Dec 14. Int J Radiat Oncol Biol Phys. 2017. PMID: 28333001 No abstract available.
VGLUT3 gates psychomotor effects induced by amphetamine.
Mansouri-Guilani N, Bernard V, Vigneault E, Vialou V, Daumas S, El Mestikawy S, Gangarossa G. Mansouri-Guilani N, et al. Among authors: vigneault e. J Neurochem. 2019 Mar;148(6):779-795. doi: 10.1111/jnc.14644. Epub 2019 Jan 15. J Neurochem. 2019. PMID: 30556914 Free article.
119 results